FORMULATIONS COMPRISING IBRUTINIB

摘要

Oral pharmaceutical formulations of ibrutinib and/or a pharmaceutically acceptable salt thereof, methods for their administration, process of their production, and use of these formulations for the treatment of diseases treatable by ibrutinib such as cancer, inflammatory diseases, and autoimmune diseases.

主权项

1. A solid oral dosage form comprising:
(i) ibrutinib and/or a pharmaceutically acceptable salt thereof; (ii) means for release of said ibrutinib and/or said pharmaceutically acceptable salt thereof in the intestine; and (iii) at least one pharmaceutically acceptable excipient.